What is new in the world of imaging?
In this article, Drug Target Review’s Hannah Balfour discusses three of the latest developments in imaging for disease research and drug development.
List view / Grid view
In this article, Drug Target Review’s Hannah Balfour discusses three of the latest developments in imaging for disease research and drug development.
Researchers have developed two novel trifluoromethylthio compounds which showed potent activity in protecting mice from Clostridioides difficile (C. diff) infection.
Researchers have identified the mechanism by which highly toxic compounds communicate, and how they use vesicles to be transported...
The team used techniques used by physicists along with highly specialised equipment to investigate deep into the bacterial membrane...
Disrupting the communication between bacteria and quinolone signalling can inhibit the the production of toxins and virulence factors...
The team found that colistin worked well with protein synthesis inhibitor antibiotics, which alone have no activity against Gram-negative bacteria...
The outer membrane surrounding the cell wall of bacteria may be a key target for approaches to a new form of antibacterial drugs...
The new imaging agent offers a non-invasive method of detecting infection and monitoring antibiotic therapy...
Researchers in dermatology at Lund University in Sweden believe they have cracked the mystery of why our bodies can quickly prevent an infection from spreading uncontrollably during wounding. They believe this knowledge may be significant in developing new ways to counteract bacteria.